SYNTHéLABO

Synthélabo is a Health Care company.

#SimilarOrganizations #More

SYNTHéLABO

Industry:
Health Care Therapeutics

Status:
Active


Similar Organizations

not_available_image

Astra

Astra is a Health Care company.

not_available_image

CollabWorx

CollabWorx is a Health Care Company.

not_available_image

Corvita

Corvita is a Health Care company.

not_available_image

Sagres Discovery

Sagres Discovery is a Health Care company.

More informations about "Synthélabo"

Sanofi - Wikipedia

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France.The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.In 2004, Sanofi …See details»

Sanofi (company) - Simple English Wikipedia, the free encyclopedia

The main directions of the company's work now are: [9] Emerging markets; Diabetes;; Vaccines; Health products; Innovative products; Animal health. Sanofi-Pasteur's vaccine division …See details»

Sanofi Synthelabo - Crunchbase Company Profile

Sanofi-Synthelabo Inc., a pharmaceutical company, provides products for physicians and patients in the healthcare industry. It focuses on various therapeutic areas, such as cardiovascular diseases and thrombosis, diseases …See details»

The Sanofi-Synthélabo Group - Encyclopedia.com

After merging with Synthelabo in 1999 the company sold off its cosmetics business and began focusing exclusively on pharmaceuticals. ... it was only in 1979 that all of its pharmaceutical …See details»

Our Company, pioneering pharmaceutical innovations | Sanofi

We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around …See details»

Synthélabo - Crunchbase Company Profile & Funding

Organization. Synthélabo . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. It is a pharmaceutical company. Acquired by . ... Synthélabo …See details»

Sanofi-Synthélabo SA - Drug pipelines, Patents, Clinical trials

Explore Sanofi-Synthélabo SA with its drug pipeline, therapeutic area, technology platform, 289 clinical trials, 319 news, and 729 literature, Disease Domain:Neoplasms, Infectious Diseases, …See details»

A look back at Sanofi's merger with Synthélabo - PMLiVE

May 24, 2013 The merger with Synthélabo was a crucial move for Sanofi, which at the time was contemplating shedding its other business areas to focus on its burgeoning pharma products. This included several recently launched major …See details»

Sanofi Synthelabo GmbH: Drug pipelines, Patents, Clinical trials

Explore Sanofi Synthelabo GmbH with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Technology Platform:Small molecule …See details»

Synthélabo - Crunchbase Company Profile & Funding

Synthélabo is a Health Care company. There is no recent news or activity for this profile.See details»

Sanofi-Synthelabo annual report 2001

Sanofi-Synthélabo's R&D organization, targeted on the group's four core therapeutic areas, uses state-of-the-art technologies. Sanofi-Synthélabo has a portfolio of 48 compounds in …See details»

Organization | Synthelabo

Founded: Paris France (1970) Status: Acquired by L'Oreal (1973) → now Sanofi-Aventis (2004)See details»

Synthélabo SA - Drug pipelines, Patents, Clinical trials - Synapse

Explore Synthélabo SA with its drug pipeline, therapeutic area, technology platform, 5 news, and 4 literature, Drug:TBC-256, Eliprodil.See details»

How Sanofi Became A Multinational Pharmaceutical Giant

Synthélabo, Hoechst, and Rhône-Poulenc Rorer all three had a long history of forming critical partnerships and absorbing the right companies to strengthen their existing businesses. ...See details»

Sanofi-Synthélabo

Synthélabo was the pharmaceutical division of L'Oréal, the world's leading company in cosmetics and beauty. L'Oréal purchased Synthélabo in 1973 to pursue ambition in the pharmaceutical …See details»

Sanofi acquires Synthélabo - 1997-02-01 - Crunchbase

Feb 1, 1997 Sanofi acquires Synthélabo on 1997-02-01 for $2000000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... Acquired Organization: Synthélabo It is a …See details»

Sanofi-Synthelabo LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Sanofi-Synthelabo LLC of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»

Sanofi Synthelabo : Uses, Dosage, Side Effects, FAQ - MedicinesFAQ

Sep 19, 2023 Sanofi Synthelabo is a synthetically derived thyroid hormone replacement preparation. It consists of levothyroxine sodium (thyroxine, T4) and liothyronine sodium …See details»

Synthélabo - Funding, Financials, Valuation & Investors - Crunchbase

Apr 1, 2004 Synthélabo . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Funding. Synthélabo has ... Synthélabo has acquired Sanofi on Apr …See details»

linkstock.net © 2022. All rights reserved